Clinical Trials
45 trialsCilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Institut Claudius Regaud
TRACE
University Hospital, Rouen
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)
Institut de Cancérologie de Lorraine
Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma
Guangxi Medical University
PREACT
Shanghai Cancer Hospital, China
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OPTIMA-II
University of Chicago
IMMUNEBOOST
UNICANCER
NICO
The Clatterbridge Cancer Centre NHS Foundation Trust
The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
BeiGene
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
University of Wisconsin, Madison
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Federation Francophone de Cancerologie Digestive
CHINOREC
Medical University of Vienna
Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer
Capital Medical University
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients
Shanghai Jiao Tong University School of Medicine
GAIN-1
University of Florida
Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Abramson Cancer Center at Penn Medicine
Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma
Instituto Nacional de Cancerologia de Mexico
Long Term Bowel Function Following Rectal Cancer Surgery
Mansoura University
TEmPoRAL
Center Eugene Marquis
Adjuvant CCRT vs CT in Minimal N2 NSCLC
Samsung Medical Center
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
M.D. Anderson Cancer Center
RectumSIB
Universitair Ziekenhuis Brussel
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Massachusetts General Hospital
NeoRes
Karolinska University Hospital
LAPACT
Celgene
TRUST
Azienda Ospedaliero, Universitaria Pisana
Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
The University of Hong Kong-Shenzhen Hospital
SPRINT
Merck KGaA, Darmstadt, Germany
LARC-RRP
Oslo University Hospital
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients
Professor Fernando Figueira Integral Medicine Institute
Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma
Samsung Medical Center
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
GlaxoSmithKline
Induction Chemotherapy for Advanced Head and Neck Cancer
Barretos Cancer Hospital
Chemoradiation for Bone Metastasis
Rabin Medical Center
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Duke University
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
ChineseAMS
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Taipei Veterans General Hospital, Taiwan
FOLFOX
Assistance Publique - Hôpitaux de Paris
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
Eli Lilly and Company
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
Chinese University of Hong Kong